Compounds > razoxane
Page last updated: 2024-08-23

razoxane and Ulcer

razoxane has been researched along with Ulcer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jensen, PB; Langer, SW; Sehested, M1
Bos, AM; van der Graaf, WT; Willemse, PH1

Other Studies

2 other study(ies) available for razoxane and Ulcer

ArticleYear
Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in mice.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:3

    Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Area Under Curve; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extravasation of Diagnostic and Therapeutic Materials; Female; Mice; Razoxane; Topoisomerase II Inhibitors; Ulcer

2001
A new conservative approach to extravasation of anthracyclines with dimethylsulfoxide and dexrazoxane.
    Acta oncologica (Stockholm, Sweden), 2001, Volume: 40, Issue:4

    Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cryotherapy; Cyclophosphamide; Dimethyl Sulfoxide; Edema; Enzyme Inhibitors; Epirubicin; Erythema; Extravasation of Diagnostic and Therapeutic Materials; Female; Fluorouracil; Free Radical Scavengers; Hand; Humans; Hydrocortisone; Infusions, Intravenous; Iron Chelating Agents; Pain; Pain Management; Razoxane; Ulcer

2001